Total Funding
57
38
Total FundingDebt Financing raised
Growth Score
-7 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
169265
Therabene is a biotechnology company that develops highly targeted PROTAC molecules to attack cancers and autoimmune diseases.
- Mario DiPaola: Founder and CEOPast Role: Blue Stream Laboratories, Founder
- Oscar Kashala: Chief Medical Officer and Executive Vice President of Global Clinical Development
About the Company
Therabene is a biotechnology company that develops highly targeted PROTAC molecules to attack cancers and autoimmune diseases.
Its founder, Dr. Mario DiPaola, is an experienced executive with a 25-year record in the biotechnology and pharmaceutical industries.
Therabene is actively seeking partnerships to advance the development of their PROTAC
molecules. They partner with academic and clinical research institutions and pharmaceutical, biopharma, and biotech companies on specific assets and disease states.
